Risks for multidrug-resistant pathogens in the ICU

I Martín-Loeches, E Diaz, J Vallés - Current opinion in critical care, 2014 - journals.lww.com
Infections with MDROs can prolong hospital stay, promote antibiotic use and prolong duration
of mechanical ventilation. Some points should be further explored in clinical research such …

Bloodstream infection in the ICU

J Vallés, R Ferrer - Infectious disease clinics of North America, 2009 - Elsevier
Hospital-acquired infections (HAI) occur in 5%–10% of patients admitted to hospitals in the
United States, and HAIs remain a leading cause of morbidity and mortality. Patients admitted …

Neumonía por Pseudomonas aeruginosa

J Vallés, D Mariscal - Enfermedades Infecciosas y Microbiología Clínica, 2005 - Elsevier
Pseudomonas aeruginosa es uno de los principales bacilos gramnegativos que causa con
mayor frecuencia neumonía nosocomial. Es además el patógeno más común causante de …

Documento de consenso sobre el tratamiento de la bacteriemia y la endocarditis causada por Staphylococcus aureus resistente a la meticilina

…, Á Soriano, J Rodríguez-Baño, J Vallés… - … y Microbiología Clínica, 2009 - Elsevier
La relevancia clínica de la bacteriemia y de la endocarditis por Staphylococcus aureus
resistente a la meticilina (SARM) es enorme. El incremento en la incidencia de bacteriemia y …

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review

…, D Mariscal, M Gallego, C Domingo, J Valles - Clinical infectious …, 1998 - JSTOR
Invasive pulmonary aspergillosis (IPA) is emerging with increasing frequency as a cause of
morbidity and mortality among immunocompromised patients, primarily those undergoing …

Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival

J Valles, J Rello, A Ochagavía, J Garnacho, MA Alcalá - Chest, 2003 - Elsevier
Design: The objectives were to characterize the prognostic factors and evaluate the impact
of inappropriate empiric antibiotic treatment and systemic response on the outcome of …

Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa

…, E Cobb, M Bodí, D Mariscal, J Vallés… - Critical care …, 2002 - journals.lww.com
Objective Pseudomonas aeruginosa is a frequent cause of ventilator-associated pneumonia.
Recent evidence suggests that production of type III secretion proteins is correlated with …

Evaluation of outcome of intravenous catheter-related infections in critically ill patients

…, M Roque, D Mariscal, E Reynaga, J Valles - American journal of …, 2000 - atsjournals.org
Fifty-seven patients developed an episode of catheter-related infection (CRI) in the bloodstream
during their stay in the intensive care unit (cases) and were prospectively observed to …

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis

J Vallés, C León… - Clinical infectious …, 1997 - academic.oup.com
A total of 590 consecutive episodes of nosocomial bacteremia were prospectively followed
in 30 intensive care units (ICUs) over a 9-month period. The crude and directly related …

Risk factors for developing pneumonia within 48 hours of intubation

J Rello, E Diaz, M Roque, J Valles - American journal of respiratory …, 1999 - atsjournals.org
Two hundred fifty intubated patients were followed during the first 48 h after intubation in
order to identify potential risk factors for developing pneumonia within this period. Thirty-two …